178 related articles for article (PubMed ID: 12470806)
1. Abeta conformational change is central to Alzheimer's disease.
Holtzman DM
Neurobiol Aging; 2002; 23(6):1085-8. PubMed ID: 12470806
[No Abstract] [Full Text] [Related]
2. Amyloid-beta: a (life) preserver for the brain.
Obrenovich ME; Joseph JA; Atwood CS; Perry G; Smith MA
Neurobiol Aging; 2002; 23(6):1097-9. PubMed ID: 12470809
[No Abstract] [Full Text] [Related]
3. Testing times for the "amyloid cascade hypothesis".
Hardy J
Neurobiol Aging; 2002; 23(6):1073-4. PubMed ID: 12470803
[No Abstract] [Full Text] [Related]
4. Bioflocculant hypothesis: a partial endorsement.
Terry R
Neurobiol Aging; 2002; 23(6):1075. PubMed ID: 12470804
[No Abstract] [Full Text] [Related]
5. Evolution and the scientific method.
Tucker HM; Estus S
Neurobiol Aging; 2002; 23(6):1093-5. PubMed ID: 12470808
[No Abstract] [Full Text] [Related]
6. Is amyloid beta-peptide neurotoxic or neuroprotective and what is its role in the binding of metal ions?
Savory J; Ghribi O; Herman MM
Neurobiol Aging; 2002; 23(6):1089-92. PubMed ID: 12470807
[No Abstract] [Full Text] [Related]
7. Abeta as a bioflocculant: implications for the amyloid hypothesis of Alzheimer's disease.
Robinson SR; Bishop GM
Neurobiol Aging; 2002; 23(6):1051-72. PubMed ID: 12470802
[TBL] [Abstract][Full Text] [Related]
8. The amyloid hypothesis: let sleeping dogmas lie?
Bishop GM; Robinson SR
Neurobiol Aging; 2002; 23(6):1101-5. PubMed ID: 12470810
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease and Alzheimer's dementia: distinct but overlapping entities.
Blass JP
Neurobiol Aging; 2002; 23(6):1077-84. PubMed ID: 12470805
[TBL] [Abstract][Full Text] [Related]
10. Pre-plaque conformational changes in Alzheimer's disease-linked Aβ and APP.
Klementieva O; Willén K; Martinsson I; Israelsson B; Engdahl A; Cladera J; Uvdal P; Gouras GK
Nat Commun; 2017 Mar; 8():14726. PubMed ID: 28287086
[TBL] [Abstract][Full Text] [Related]
11. Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice.
Wirths O; Multhaup G; Czech C; Blanchard V; Moussaoui S; Tremp G; Pradier L; Beyreuther K; Bayer TA
Neurosci Lett; 2001 Jun; 306(1-2):116-20. PubMed ID: 11403971
[TBL] [Abstract][Full Text] [Related]
12. Probing amyloid-β pathology in transgenic Alzheimer's disease (tgArcSwe) mice using MALDI imaging mass spectrometry.
Carlred L; Michno W; Kaya I; Sjövall P; Syvänen S; Hanrieder J
J Neurochem; 2016 Aug; 138(3):469-78. PubMed ID: 27115712
[TBL] [Abstract][Full Text] [Related]
13. Medicine. Prion-like behavior of amyloid-beta.
Kim J; Holtzman DM
Science; 2010 Nov; 330(6006):918-9. PubMed ID: 21071652
[No Abstract] [Full Text] [Related]
14. Induction of amyloid-β deposits from serially transmitted, histologically silent, Aβ seeds issued from human brains.
Hérard AS; Petit F; Gary C; Guillermier M; Boluda S; Garin CM; ; Lam S; Dhenain M
Acta Neuropathol Commun; 2020 Nov; 8(1):205. PubMed ID: 33250056
[TBL] [Abstract][Full Text] [Related]
15. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
[TBL] [Abstract][Full Text] [Related]
16. Cross-species genetic screens to identify kinase targets for APP reduction in Alzheimer's disease.
Huichalaf CH; Al-Ramahi I; Park KW; Grunke SD; Lu N; de Haro M; El-Zein K; Gallego-Flores T; Perez AM; Jung SY; Botas J; Zoghbi HY; Jankowsky JL
Hum Mol Genet; 2019 Jun; 28(12):2014-2029. PubMed ID: 30753434
[TBL] [Abstract][Full Text] [Related]
17. Cat and mouse.
Cole GM; Frautschy SA
Neuron; 2006 Sep; 51(6):671-2. PubMed ID: 16982408
[TBL] [Abstract][Full Text] [Related]
18. Plant-based chimeric HPV-virus-like particles bearing amyloid-β epitopes elicit antibodies able to recognize amyloid plaques in APP-tg mouse and Alzheimer's disease brains.
Gonzalez-Castro R; Acero Galindo G; García Salcedo Y; Uribe Campero L; Vazquez Perez V; Carrillo-Tripp M; Gevorkian G; Gomez Lim MA
Inflammopharmacology; 2018 Jun; 26(3):817-827. PubMed ID: 29094307
[TBL] [Abstract][Full Text] [Related]
19. Intracerebral Injection of Metal-Binding Domain of Aβ Comprising the Isomerized Asp7 Increases the Amyloid Burden in Transgenic Mice.
Kulikova AA; Cheglakov IB; Kukharsky MS; Ovchinnikov RK; Kozin SA; Makarov AA
Neurotox Res; 2016 May; 29(4):551-7. PubMed ID: 26842600
[TBL] [Abstract][Full Text] [Related]
20. beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease.
Terai K; Iwai A; Kawabata S; Tasaki Y; Watanabe T; Miyata K; Yamaguchi T
Neuroscience; 2001; 104(2):299-310. PubMed ID: 11377835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
